Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722327
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-02-01
Brief Title:
Phase I Trial of Adagrasib MRTX849 in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center